Ferric 1-glycerophosphate
Common Name: |
Ferric 1-glycerophosphate |
IUPAC Name: |
2,3-dihydroxypropyl phosphate;iron(3+) |
Molecular Formula: |
C9H21Fe2O18P3 |
SMILES: |
C(C(COP(=O)([O-])[O-])O)O.C(C(COP(=O)([O-])[O-])O)O.C(C(COP(=O)([O-])[O-])O)O.[Fe+3].[Fe+3] |
Inchi: |
1S/3C3H9O6P.2Fe/c3*4-1-3(5)2-9-10(6,7)8;;/h3*3-5H,1-2H2,(H2,6,7,8);;/q;;;2*+3/p-6 |
Inchi Key: |
AORRAZSRUFKDBZ-UHFFFAOYSA-H |
Cas No: |
1301-70-8 |
Name |
Value |
Lipinski Violations |
3 |
Ghose Violations |
2 |
Veber Violations |
2 |
Egan Violations |
1 |
Muegge Violations |
5 |
Name |
Value |
Molecular Weight (g/mol) |
621.86 |
Mass (g/mol) |
621.864 |
Molar Refractivity |
83.60 |
Net Charge |
|
HBD |
6 |
HBA |
18 |
Rt Bonds |
12 |
Rings |
|
TPSA |
368.07 |
Hetero Atoms |
|
Heavy Atoms |
32 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
488.00 to 489.00 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
|
iLOGP |
0.00 |
XLOGP3 |
-8.57 |
WLOGP |
-2.03 |
MLOGP |
-6.31 |
ESOL Log S |
2.50 |
ESOL Solubility (mg/ml) |
195000 |
ESOL Solubility (mol/l) |
313 |
ESOL Class: esol_class |
Highly soluble |
Ali Log S |
1.61 |
Ali Solubility (mg/ml) |
25500 |
Ali Solubility (mol/l) |
41 |
Ali Class |
Highly soluble |
Silicos-IT LogSw |
1.81 |
Silicos-IT Solubility (mg/ml) |
40000 |
Silicos-IT Solubility (mol/l) |
64.3 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
Low |
BBB Permeable |
0 |
PgP Substrate |
1 |
Log Kp (cm/s) |
-16.18 |
Bioavailability Score |
0.17 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.797 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
3.251 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
1 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |